Moderator: G. Soubrane FRANCE
Welcome and Introduction

G. Lang GERMANY 
New Insights on the Pathogenesis of DME

E. Midena ITALY
Defining Outcomes in the Treatment of DME. What Should the Ophthalmologist be Monitoring?

P. Scanlon UK 
Defining Outcomes in the Treatment of DME. What is the Impact of DME and its Treatment on Patient Quality of Life?

M. Porta ITALY
Best-Practice Management of the Diabetic Patient

Questions and Answers

Summary and Close

13:00

J. Korobelnik FRANCE
Setting the standard for patient care: ranibizumab in neovascular AMD

13:10

F. Bandello ITALY
Improving vision-related function: recent evidence from clinical trials with ranibizumab

13:25

S. Sharma CANADA
Optimizing patient outcomes: maximizing patient safety

13:35

P. Mitchell AUSTRALIA
Predictors of treatment response in neovascular AMD: implications for patient management

13:50

Panel discussion

14:00

Close

Moderator: Y. Le Mer FRANCE

I. Jürgens SPAIN
Advances & Clinical Pearls in 23G and 25G Vitrectomy

C. Awh USA
Stellaris PC, A True Combination Platform: Features & Benefits                 

P. Stodulka CZECH REPUBLIC
Field Experience with the Stellaris PC

Moderator: A. Augustin GERMANY

A. Augustin GERMANY
Opening Remarks

A. Loewenstein ISRAEL 
Exudative AMD Subtypes: RPE-Detachments, RAP, and Polypoidal Choroidal Vasculopathy

A. Augustin GERMANY
Medical and Surgical Approaches to Diabetic Macular Edema

C. Claes BELGIUM
Diabetic Retinopathy: New Trends and Techniques

S. Rizzo ITALY
Conventional Retinal Detachment Surgery Versus Primary Vitrectomy: Techniques, Complications and Results

A. Augustin GERMANY
Closing Comments

Reception to follow

Moderator: J. F. Korobelnik FRANCE
Speakers: M. N. Delyfer FRANCE, M. B. Rougier FRANCE

Moderators: G. Coscas FRANCE , F. Bandello ITALY
Introduction and Welcome

J. Ambati USA
Inflammation and Retinal Disease, is There More to it Than VEGF?

A. Kampik GERMANY
Steroids in Management of Macular Edema – A relevant option to anti-VEGF therapy

S. Lightman UK
Steroids in Management of Uveitis

F. Bandello ITALY
Combination therapy, the future for Macular Disease Management?

A. Loewenstein ISRAEL
Patient cases - Panel debate

Speakers:
P. Lanzetta
A  Augustiin
P. Udaondo
S. Gupta

Moderator: C. Eckardt GERMANY

Dr. Bertelli ITALY
23G Surgery

T. Jackson UK
New DORC Posterior Dyes & New Generation 23G

P.  Stalmans BELGIUM
New Dual Associate

C. Eckardt GERMANY
New Generation 23G & New Developments

B. Parolini ITALY
23G Surgery  

P. Szurman  GERMANY
New DORC Posterior Dyes & New Generation 23G